PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie co
AbbVie Inc.
Failed Stability Specifications
Source: FDA Drug Enforcement (openFDA API)
50 recalls— updated every few hours from the FDA's drug enforcement database.
Medication recalls are issued when a prescription or over-the-counter drug is found to be defective, contaminated, or otherwise unsafe. The FDA's Center for Drug Evaluation and Research (CDER) oversees drug recalls in the United States and maintains the enforcement action database that powers this page.
Common causes of drug recalls include microbial or chemical contamination during manufacturing, incorrect potency (meaning a dose contains more or less of the active ingredient than labeled), labeling errors that could lead to medication errors, the presence of foreign particles or sub-potent ingredients, and products that fail sterility testing. In some cases, recalls occur because a facility failed to meet Good Manufacturing Practice (GMP) standards, even if no specific product defect has been identified yet.
Drug recalls are classified the same way as food recalls. A Class I recall means there is a reasonable probability that using the product will cause or lead to serious adverse health consequences or death — for example, a blood pressure medication with no active ingredient, or an injectable drug contaminated with bacteria. A Class II recall covers products that may cause temporary, reversible health effects. A Class III recall involves products that are unlikely to cause harm but violate FDA regulations.
If you take a recalled medication, do not stop taking a prescription without speaking to your doctor or pharmacist first — abruptly discontinuing some medications can be dangerous. Bring the recalled product to your pharmacy; they can check lot numbers and arrange a replacement. Never flush medication down the toilet unless the recall notice specifically instructs you to. Use the FDA's drug take-back program or an approved disposal method.
AbbVie Inc.
Failed Stability Specifications
AVEVA Drug Delivery Systems, Inc.
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
IntegraDose Compounding Services LLC
Subpotent Drug
ANI Pharmaceuticals, Inc.
Defective Container; packets were found to be either empty or partially full.
Haleon US Holdings LLC
Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.
UCB Biosciences Inc.
Lack of Assurance of Sterility
Sagent Pharmaceuticals
Failed Impurities/Degradation Specifications
Amerisource Health Services LLC
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Amerisource Health Services LLC
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Safecor Health, LLC
Presence of a Foreign Substance; black particles observed in liquid
Safecor Health, LLC
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
Zydus Pharmaceuticals (USA) Inc
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Zydus Pharmaceuticals (USA) Inc
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
B BRAUN MEDICAL INC
Presence of Particulate Matter.
Oasis Medical, Inc.
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.
Golden State Medical Supply Inc.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Golden State Medical Supply Inc.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Ascend Laboratories, LLC
Failed Dissolution Specifications
Lupin Pharmaceuticals Inc.
Presence of particulate matter: a white thread-like structure in the cartridge
Wisconsin Pharmacal Company
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Teva Pharmaceuticals USA, Inc
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Lannett Company Inc.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Thea Pharma, Inc.
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
Thea Pharma, Inc.
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
JB Chemicals and Pharmaceuticals Ltd
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
CareFusion 213, LLC
Lack of assurance of Sterility: potential product contamination
CareFusion 213, LLC
Lack of assurance of Sterility: potential product contamination
Alcon Research LLC
Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Alcon Research LLC
Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
Acella Pharmaceuticals, LLC
Chemical contamination; presence of lead and lithium above specification
SCOPE HEALTH
Lack of Assurance of Sterility
Harrow Eye LLC
Lack of Assurance of Sterility
American Regent, Inc.
Labeling: Missing Label
Premier Dental Products Co
Labeling: Incorrect or Missing Lot and/or Exp Date:The expiration date has an extra digit and is printed as 2709114 instead of the correct 270914 (2027-09-14). It is important to note that this error is limited to the vial itself; the saleable unit of the box of 12 bottles has the correct expiration date printed.
Unichem Pharmaceuticals USA Inc.
Subpotent drug
The Harvard Drug Group LLC
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Apotex Corp.
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Hikma Pharmaceuticals USA INC
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Water-Jel Technologies, LLC
Failed PH Specifications
Teva Pharmaceuticals USA, Inc
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
Fresenius Medical Care Holdings, Inc.
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
Fresenius Medical Care Holdings, Inc.
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
B BRAUN MEDICAL INC
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
B BRAUN MEDICAL INC
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Huons Co., Ltd.
Lack of Assurance of Sterility
Huons Co., Ltd.
Lack of Assurance of Sterility